Sepsis is an infection-induced systemic inflammatory syndrome and a major cause of death for critically ill patients. Here, we examined whether the absence of Sprouty-related EVH1-domain-containing protein 2 (Spred2), a negative regulator of the Ras/Raf/ERK/MAPK pathway, influences host defense against polymicrobial sepsis (PMS) induced by cecal ligation and puncture (CLP). Compared to wildtype mice, Spred2 −/− mice exhibited higher survival rates with increased level of leukocyte infiltration and local chemokine production and reduced plasma and peritoneal bacterial loads after CLP. The MEK inhibitor U0126 significantly reduced LPS-induced chemokine production by Spred2 −/− resident macrophages in vitro, and decreased CLP-induced leukocyte infiltration in vivo. Spred2 −/− resident macrophages, but not neutrophils or elicited macrophages, exhibited increased phagocytic activity. Interestingly, surface expression of complement receptor 1/2 (CR1/2) was increased in Spred2 −/− resident macrophages in response to lipopolysaccharide in a manner dependent on the ERK/MAPK pathway, and blocking CR1/2 in vivo resulted in reduced leukocyte infiltration and increased bacterial loads after CLP. Taken together, our results indicate that Spred2-deficiency protects mice from PMS via increased activation of the ERK/MAPK pathway and subsequent increase in innate immune responses. Thus, inhibiting Spred2 may present a novel means to prevent the development of PMS.
1
. Despite advances in supportive care, the mortality rate of sepsis (30-50%) remains unchanged for the past three decades and is the leading cause of death in noncoronary intensive care unit 2 . Sepsis is a huge burden for healthcare systems, and the management and treatment of sepsis remain challenging.
The pathophysiology of sepsis involves dysregulation of the inflammatory response, coagulation abnormalities and multiple organ failure, resulting from the actions of numerous mediators belonging to the complement system, coagulation cascade, fibrinolysis cascade and cytokines/chemokines 1, 3 . Following pathogen infection or tissue damage, the innate immune system recognizes microbial components by pattern recognition receptors (PRRs), and induces host responses through the activation of intracellular signal transduction pathways 4 .
There is a great interest in studying the cellular processes and signaling pathways during sepsis. We have thus far demonstrated using a murine model of septic peritonitis that signal transducer and activator of transcription (STAT) and its negative regulator suppressors of cytokine signaling (SOCS) have a significant impact on innate immune responses during sepsis [5] [6] [7] [8] . During sepsis, bacterial components that include lipopolysaccharide (LPS) activate several intracellular signaling pathways, including the NF-κB and MAPK pathways 9, 10 . The MAPK family is composed of the c-Jun N-terminal kinase (JNK)-1/2, p38 and extracellular signal-regulated kinase (ERK)-1/2 11 .
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Among them, activation of ERK was detected in LPS-induced endotoxemia and septic peritonitis induced by cecal ligation and puncture (CLP) which closely resembles the clinical course of polymicrobial peritonitis, bacteremia, and systemic sepsis in humans 9, [12] [13] [14] . Thus, the ERK pathway appears to play an essential role in the pathogenesis of sepsis and septic shock.
Sprouty-related EVH1-domain-containing proteins (Spreds) are a family of proteins that inhibit Ras-dependent ERK signaling 15 . As the ERK/MAPK pathway is activated in sepsis and septic shock, endogenous Spred proteins may be involved in the regulation of immune responses during sepsis. However, the physiological functions of Spred proteins in sepsis remain to be elucidated. Spred1 and 3 are selectively expressed in the brain and cerebellum, whereas Spred2 is ubiquitously expressed in various tissues, including the colon, lung and spleen 16, 17 . We recently demonstrated that Spred2-deficiency exacerbated LPS-induced lung inflammation with increased leukocyte infiltration by up-regulating the ERK/MAPK pathway 18 , leading us to hypothesize that interfering Spred2 may be useful to protect hosts against microbial infection. In the present study, we demonstrate, for the first time, that Spred2-deficiency protects mice from CLP-induced polymicrobial sepsis (PMS). Interestingly, phagocytic activity was significant enhanced in Spred2-deficient macrophages, via augmented cell-surface expression of complement receptor 1 and 2 (CR1/2). Thus, Spred2 may represent a novel therapeutic target to prevent the development of PMS.
Results

Enhanced innate immune responses in Spred2
−/− mice after CLP. To test the hypothesis that interfering Spred2 protects mice from PMS, we first induced septic peritonitis in WT and Spred2 −/− mice by CLP and examined the survival of mice. We used 18-G needles to puncture cecum. As shown in Fig. 1a, 9 out of 16 (56%) WT mice died by day 2 and 13 out of 16 (81%) died by day 10. In contrast, 7 out of 16 (44%) Spred2 −/− mice died. Thus, Spred2
−/− mice were protected from PMS caused by CLP. Leukocytes, such as neutrophils and macrophages, are the first line of cells that encounter and respond to pathogens after CLP 7 . Therefore, we examined the infiltration of these leukocyte subsets into the peritoneum after CLP. Since the puncture with 18-G needles caused a heavy leak of intestinal contents that made the examination difficult, we used 22-G needles that induce milder PMS 19 . As shown in Fig. 1b , there was no significant difference in the numbers of total leukocytes, neutrophils or macrophages at 6 h after the surgery. At 24 h, however, the numbers of total leukocytes and each cell types infiltrating the peritoneum were higher in Spred2 −/− mice, compared to WT mice (1.3-fold increase for neutrophils and 1.4-fold increase for macrophages). The differences were modest but statistically significant.
We next measured the concentration of proinflammatory cytokines, including TNFα, IL-1β and IL-6, and chemokines, including CXCL1 and CCL2, in the peritoneal lavage fluid obtained at 6 or 24 h after CLP. There was no significant difference in the level of TNFα or IL-1β, in the peritoneal fluids between the two groups at both time points (data not shown). There was also no difference in the level of IL-6, CXCL1 and CCL2 at 6 h between the two groups (data not shown). However, the levels of IL-6, CXCL1 and CCL2 at 24 h were moderately but significantly elevated in the peritoneal fluids of Spred2 −/− mice relative to those of WT mice (Fig. 1c) . The levels of these molecules in the serum at 24 h were much lower than those in the lavage fluids, but the levels of IL-6 and CCL2 were significantly elevated (Fig. 1d) .
We also examined the bacterial load in the peritoneum and peripheral blood of mice after CLP. As shown in Fig. 1e , bacterial loads detected at 24 h after CLP in the peritoneum (left panel) and peripheral blood (right panel) of Spred2
−/− mice were significantly lower than those of WT mice, indicating that Spred2 −/− mice had a greater capacity to clear bacteria post CLP. Taken together, our results suggest that Spred2 −/− mice were protected from CLP-induced sepsis likely due to increased inflammatory responses against bacteria.
Augmented chemokine production by Spred2
−/− macrophages. TLR4 plays a critical role in coordinating complex immune responses to bacterial infections 20 . To examine whether Spred2-deficiency affects the production of cytokines and chemokines, we isolated resident peritoneal macrophages from WT and Spred2 −/− mice and stimulated them with the TLR4 ligand LPS. There was only a low level of IL-6, CXCL1 or CCL2 in the culture supernatant when the cells were not activated, and there was no difference in the production of these molecules between WT and Spred2 −/− macrophages (Fig. 2a) . As shown in Fig. 2b , however, macrophages from Spred2 −/− mice produced significantly higher levels of IL-6, CXCL1 and CCL2 than those from WT mice. To examine whether this enhanced chemokine production by Spred2 −/− macrophages was mediated through the activation of ERK, macrophages were stimulated with LPS in vitro in the presence of U0126, an inhibitor of MAP Kinase Kinase (MAPKK or MEK1/2). U0126 significantly reduced LPS-induced production of IL-6, CXCL1 and CCL2 by macrophages (Fig. 2c) . When U0126 was injected into WT mice before CLP, it significantly decreased CLP-induced neutrophil and macrophage infiltration at 24 h post CLP (Fig. 2d) . These results indicate that the production of IL-6, CXCL1 and CCL2 was up-regulated in resident peritoneal macrophages of Spred2 −/− mice via activation of the MAPK pathway and that increased neutrophil and macrophage infiltration detected after CLP was due to increased activation of the MAPK pathway.
Augmented phagocytosis of bacteria by Spred2
−/− macrophages. It was previously demonstrated that infiltrating leukocytes clear bacteria from the peritoneum in this model 8, 21 . A lower level of bacterial loads detected in Spred2 −/− mice can be ascribed to the increased number of infiltrating leukocytes, but it is also possible that Spred2 −/− leukocytes have a higher capacity to clear bacteria. To better understand the mechanism of increased bacterial clearance by Spred2
−/− mice, we examined the phagocytic activity of leukocytes. We first isolated peritoneal resident cells from untreated WT or Spred2 −/− mice and incubated them with Alexa Fluor 488-conjugated Escherichia coli bioparticles. As shown in Fig. 3a , peritoneal resident macrophages from Spred2 −/− mice exhibited augmented phagocytic activity relative to WT control as indicated by increased mean fluorescence intensity (MFI). The augmented phagocytic activity was ascribed to macrophages, as it was observed in Spred2 −/− F4/80 + -cells, but not F4/80 − -cells that were less then 5% of the total cells (data not shown). We next examined the phagocytic activity of peritoneal exudate leukocytes. We isolated cells at 16 h after TG-injection (>85% neutrophils) and cells were incubated with Alexa Fluor 488-conjugated Escherichia coli bioparticles. Cells were gated with Ly6G or F4/80 and phagocytosis of bioparticules was analyzed by flow cytometer. Unlike resident macrophages, no difference was found between Ly6G + or F4/80 + cells from WT and Spred2 −/− mice (Fig. 3b ). Phagocytosed bacteria are killed by leukocytes in association with the production of ROS 22 . Therefore, the production of ROS was examined using TG-elicited 16 h peritoneal exudate cells (PEC). As shown in 
WT and Spred2
−/− cell. Resident macrophages from WT and Spred2 −/− mice also produced similar amounts of ROS (data not shown). Thus, Spred2
−/− resident macrophages exhibited augmented phagocytic capacity but there was no difference in ROS production.
Increased cell-surface expression of CR1/2 on Spred2
−/− macrophages via the ERK/MAPK pathway. Several cell-surface molecules, including CD64 (Fcγ receptor 1) 23 , I-A/I-E (MHC class ΙΙ) 24 , CR1/2 25 and TLR4 26 , have been shown to play a role in the phagocytosis of bacteria. To understand the mechanisms of −/− mice, pretreated with DMSO or U0126, were counted at 24 h after CLP. Data represent the mean ± SEM. n = 4 for (a) and n = 10 for other experiments. *p < 0.05, **p < 0.01 and ***p < 0.001.
enhanced phagocytosis by Spred2
−/− resident macrophages, we evaluated the expression of these cell-surface molecules. The expression of these molecules was similar on unstimulated macrophages from either WT or Spred2 −/− mice (data not shown). However, upon stimulation with LPS, Spred2 −/− resident macrophages expressed significantly higher levels of CR1/2 than WT macrophages (Fig. 4a) . The expression level of CR1/2 on freshly isolated resident macrophages was similar between the two strains (data not shown).
We next examined the involvement of the ERK/MAPK pathway in the regulation of CR1/2 expression by macrophages. Peritoneal resident macrophages from Spred2 −/− mice were stimulated with 10 ng/ml LPS in the presence or absence of U0126 for 24 hours and the expression of CR1/2 was analyzed by flow cytometry. Interestingly, U0126 significantly decreased the surface expression of CR1/2 on Spred2 −/− resident macrophages (Fig. 4b) . 
Increased inflammatory responses in Spred2
−/− mice via activation of CR1/2. To examine a potential role of CR1/2 in the augmented inflammatory responses detected in Spred2 −/− mice after CLP, a neutralizing anti-CR1/2 antibody (3 μg/mouse) was intraperitoneally injected into Spred2 −/− mice 2 h prior to CLP. As shown in Fig. 5a , injection of anti-CR1/2 antibody decreased the peritoneal levels of IL-6, CXCL1 and CCL2 (Fig. 5a ) and peritoneal leukocyte infiltration after CLP (Fig. 5b) . Furthermore, the bacterial burden was conversely increased (Fig. 5c ). These findings strongly support the notion that the increased expression of CR1/2 on Spred2 −/− macrophages was responsible for the enhanced innate immune responses detected in Spred2 −/− mice in response to CLP.
Discussion
We previously reported that Spred2-deficiency promoted the development of LPS-induced lung inflammation by up-regulating the production of proinflammatory cytokines and chemokines 18 . We also demonstrated that Spred2-deficiency exacerbated acetaminophen-induced hepatotoxicity via increased production of cytokines and chemokines by Kupffer cells and NK cells 27 . Since cytokine and chemokine responses are essential in the development of innate immunity against bacterial infections, including septic peritonitis, we hypothesized that Spred2-deficiency might protect mice from septic peritonitis. In the present study, we tested the hypothesis and found that Spred2 −/− mice, compared to WT mice, were indeed protected from PMS after CLP. The increased protection against PMS appeared to be due to the increased infiltration of inflammatory cells, such as neutrophils and macrophages, and also increased phagocytic activity by peritoneal resident macrophages. Increased cell-surface expression of CR1/2, which was regulated by the MAPK pathway, was at least partially responsible for the enhanced phagocytic activity. Although there have been numerous reports describing the roles of the MAPK pathway in innate and adaptive immune responses, this is the first report demonstrating the relationship between the MAPK pathway and cell-surface expression of CR1/2 by macrophages.
We detected elevated levels of cytokines and chemokines, including IL-6, CXCL1 and CCL2, in the peritoneal fluid of Spred2 −/− mice. IL-6 can be produced and released by T cells and macrophages and is considered to be a clinical marker of severe sepsis that could lead to high morbidity and mortality 28 . Our results, however, were incompatible with previous results because Spred2 −/− mice showed better survival in spite of a higher level of IL-6 production. This apparent discrepancy could be explained by the production of other cytokines/chemokines or the capacity of bacterial clearance. For example, CCL2 was previously shown to protect mice from endotoxemia. The administration of a neutralizing monoclonal antibody against CCL2 or genetic disruption of the CCL2 gene was associated with increased mortality rates in mice with sepsis 29, 30 . Small differences between the level of these molecules produced by WT or Spred2 −/− macrophages were likely due to the puncture by 22-G needles which caused much milder PMS than that by 18-G needles.
Murine CR2 (CD21) and CR1 (CD35) are alternative splicing products of the Cr2 gene. CR2 is expressed on B cells and follicular dendritic cells, whereas CR1 is expressed on various kinds of cells, including macrophages, erythrocytes, B and T lymphocytes 31 . CR1 and 2 bind to C3b and C3d, respectively, and were shown to play a pivotal role in innate and adaptive immunity, involving phagocytosis, complement regulation and maintenance of germinal center B cells and memory B cells 32, 33 . Moreover, Donius et al. have reported that CR1/2-deficiency resulted in a higher mortality rate in a Streptococcus pneumoniae-induced pneumonia model 34 . These findings are consistent with our result that the expression of CR1/2 was enhanced in Spred2 −/− macrophages in vitro and responsible for increased inflammatory responses and bacterial clearance detected in Spred2 −/− in vivo. The MAPK pathways are one of the most important signal transduction systems, which induce innate and adaptive immune responses. Inhibition or deletion of MAPKs, including ERK1/2, p38 and JNK, resulted in various immunological dysfunctions 11 . As described above, Spred2 is shown to inhibit the Ras/Raf/MAPK pathway by binding to Raf 27 . Raf is an important signaling molecule downstream of various growth factor receptors, but not of cytokine receptors. In this study, an increase in cytokine/chemokine production and cell-surface CR1/2 expression by Spred2 −/− macrophages in response to LPS was blocked by U0126, suggesting that Spred2 may be involved in the regulation of the MAPK pathway downstream of TLR4. The MAPK pathway is demonstrated to regulate the expression of proinflammatory cytokines/chemokines 11 and also the trafficking of receptors, such as bradykinin B2 receptor 35 . However, the exact mechanisms whereby Spred2 plays a role in TLR4 signaling pathway remains unclear. Zhu et al. recently reported that tuberous sclerosis complex 1 (TSC1) inhibits M1 polarization of mouse macrophages by suppressing the Ras/Raf1/MEK/ERK pathway 36 . Further, TSC1 −/− macrophages produced higher levels of cytokines in response to LPS. Thus, Spred2 may control cytokine/chemokine production by inhibiting Raf. It is also possible that Spred2 suppresses TLR signaling by other unknown mechanism. Additional studies are necessary to determine exact mechanisms by which Spred2 controls the development of innate immune responses.
Materials and Methods
Reagents. Fluorescein isothiocyanate (FITC)-or phycoerythrin (PE)-conjugated anti-F4/80, purified or PE-conjugated anti-CD21/35 (CR 2/1, clone 7E9) and PE-conjugated anti-I-A/I-E were purchased from BioLegend (San Diego, CA). FITC-conjugated Ly6G (RB6-8C5), PE-conjugated anti-Toll-like receptor 4 (TLR4) and PE-conjugated anti-CD64 were from BD Biosciences (San Jose, CA). U0126 was purchased from Calbiochem (Merck KGaA, Darmstadt, Germany).
Mice. Spred2
−/− mice on a C57BL/6J background were generated, as previously described 37, 38 . No Spred2 expression was detected in peritoneal cells, spleens, lungs, livers and kidneys from Spred2 −/− mice, as assessed by TaqMan RT-qPCR (data not shown). C57BL/6J mice were used as the wild-type (WT) mice. These mice were bred at the Department of Animal Resources, Okayama University (Okayama, Japan). Male mice (10-12 weeks) were used in this study under specific pathogen-free conditions. The mice were housed in a temperature-controlled environment with a 12-h light/12-h dark cycle and allowed free access to water and food. All animal protocols were approved by the Animal Care and Use Committee of the Okayama University, and all experiments were performed in accordance with relevant guidelines and regulations.
Induction of PMS.
CLP surgery was performed as described in previous literatures 39, 40 . In brief, mice were anesthetized by an intraperitoneal injection of ketamine (50 μg/kg body weight) and pentobarbital sodium (40 μg/ kg body weight), and a 1 cm midline incision was made through the abdomen. The cecum was exposed and ligated with a 3-0 silk suture at half the distance between its distal pole and its base, and punctured through twice with an 18-or 22-gauge needle. The incision was closed with surgical clips. Mice were resuscitated with subcutaneous injection of 1 ml of warm sterile saline. Antibiotics were not given. The same surgical procedures were performed on sham animals without ligation and puncture. To evaluate the survival rate, mice were monitored for 10 days after CLP. In a different set of experiments, mice were anesthetized, bled, and euthanized 24 h after CLP. The peritoneal cavities were washed with 3 ml of cold sterile PBS, lavage fluids were harvested under sterile conditions. A 5-μl aliquot of lavage fluid and peripheral blood from each mouse were used for the assessment of bacteria load as described below. The remaining lavage fluids were centrifuged at 400 × g for 6 min at 4 °C.
Cell-free peritoneal fluids were separated and stored at −80 °C until use. Cell pellets were resuspended in saline, and cell numbers were counted in a hemocytometer. Differential cell analyses were made by Diff-Quik staining of the smear slides or by flow cytometry.
Determination of bacterial loads. Peritoneal lavage fluids or peripheral blood were serially diluted with sterile saline, and 5 μl of each diluted sample was plated on trypticase soy agar (TSA) plates with 5% sheep blood and incubated overnight at 37 °C, after which the number of aerobic bacterial colonies was counted. Data are presented as colony forming unit (CFU) ± SEM.
Preparation of macrophages and neutrophils. Resident peritoneal cells were harvested from non-treated mice and 1 × 10 6 cells were incubated for 1 h at 37 °C in antibiotics-free RPMI 1640 containing 5% FCS in 6-well culture plates. Each well was rinsed three times with sterile PBS, and adherent macrophages were cultured in RPMI-1640 supplemented with 5% FCS. Higher than 96% of adherent cells were F4/80-positive as determined by flow cytometer and used as macrophages. In a different set of experiments, mice were intraperitoneally injected with 1 ml of 4% thioglycollate (TG, Difco Laboratories, Detroit, MI) and PEC were harvested from the peritoneum 16 h after the injection. Neutrophils and macrophages were identified as Ly6G-positive and F4/80-positive by flow cytometer, respectively. Cell viability was routinely greater than 95%, as determined by trypan blue exclusion.
Activation of macrophages.
To evaluate the production of cytokines and chemokines by macrophages, adherent macrophages described above were stimulated with 100 ng/ml of LPS. After a 24 h-incubation, cell-free culture supernatants were harvested and stored at −80 °C until use. In a different set of experiments, peritoneal resident macrophages were incubated with 100 ng/ml LPS in the presence of 5 μM U0126 or vehicle control (DMSO) for 24 hours.
Phagocytic activity. Phagocytic activity of peritoneal macrophages and neutrophils was determined using Alexa Fluor 488-conjugated Escherichia coli bioparticles (E-13231, Thermo Fisher Scientific K.K, Yokohama, Japan), as previously described 41, 42 . Briefly, peritoneal macrophages or TG-induced 16 h PEC (1 × 10 6 cells per well in a 6-well plate) were suspended in antibiotic-free RPMI 1640 with 5% FBS, and co-cultured with 1 × 10 6 bioparticles for 1 h at 37 °C in a tissue culture plastic plate. Cells were then scraped off the surface and un-phagocytosed bioparticles that attached the cell surface were quenched by 0.4% trypan blue for 1 min. The fluorescent intensity of cells was measured by flow cytometry.
Measurement of reactive oxygen species (ROS) production.
For the measurement of ROS production, peritoneal resident macrophages or TG-induced 16-h PEC were stimulated with 100 ng/mL of LPS for 4 hours and then stained with 10 μL CellROX green reagent (5 μM, Thermo Fisher Scientific) or vehicle control (DMSO) for 30 minutes at 37 °C. Cells were then washed with PBS and analyzed on a flow cytometer. Neutrophils and macrophages were gated with Ly6G-and F4/80-staining, respectively. Measurement of cytokine concentrations. The concentration of cytokines and chemokines in peritoneal lavage fluids or culture supernatants were measured by a standard method of sandwich ELISA, as previously described 6, 43 . Captured antibodies, detection antibodies and recombinant cytokines were purchased from R&D Systems (Minneapolis, MN). ELISAs employed in this study did not cross-react with other murine cytokines available.
